ABSTRACT:

Background: currently obesity and overweight are two of the major public health problems worldwide, which haunts the health of more and more young people around the world, as this problem advances so does medicine, treatments and surgical procedures, such is the case of bariatric surgeries, which can have a great positive impact on the lives of patients who undergo these procedures, however, there are also post-surgical complications, such as acute cholestatic syndromes, which are becoming more and more frequent, so finding and describing a treatment to avoid these complications could be a fundamental piece in the management of these patients.
Methods: We conducted a purely observational and descriptive study by collecting data and information through a national and international literature review, where we selected control cases and meta-analysis which are detailed and described during this review.
Results: During the last years the popularity of the use of ursodeoxycholic acid has grown, since it has been mentioned its use out of indications as a prophylactic treatment after bariatric surgery, this alternative may sound favorable for the treating physician and for the patient, since it is safe and avoids complications according to different studies.
Conclusions: Multiple studies, including all those reviewed during this research show a highly positive benefit of the use of ursodeoxycholic acid, it is noteworthy that during this research, the only study that does not mention a positive effect of the use of ursodeoxycholic acid is the study of Muriel Coupaye et al. which mentions that no difference was found between the groups treated and not treated with ursodeoxycholic acid with 500mg/day.

KEYWORDS:

Ursodeoxycholic Acid, bariatric surgery, cholestatic syndromes, gallbladder stones, cholecystectomy.

REFERENCES :

1) World Health Organization: WHO. (2024, 1 march). Obesidad y sobrepeso. https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight
2) Maluenda, G. F. (2012). Cirugía bariátrica. Revista Médica Clínica Las Condes, 23(2), 180-188. https://doi.org/10.1016/s0716-8640(12)70296-1
3) Shuchleib, A., Shuchleib, M., & Zundel, N. Cirugía bariátrica y colelitiasis. Revista Latinoamericana de Cirugía, 65.
4) Lasnibat, J. P., Molina, J. C., Lanzarini, E., Musleh, M., von Jentschyk, N., Valenzuela, D., …& Braghetto, I. (2017). Colelitiasis en pacientes obesos sometidos a cirugía bariátrica: estudio y seguimiento postoperatorio a 12 meses. Revista chilena de cirugía, 69(1), 49-52. https://doi.org/10.1016/j.rchic.2016.07.007
5) Pimienta-Sosa, A. P., & Medina-Sánchez, C. E. (2023). Colecistectomía en el paciente bariátrico:¿ antes, durante o después de bypass gástrico?. Cirujano general, 45(1), 21-26. https://dx.doi.org/10.35366/110699
6) Alsallamin, I., Chakhachiro, D., Bawwab, A., Nassar, M., & Alsallamin, A. (2023). Prevalence of symptomatic gallbladder disease after bariatric surgery: a literature review. Cureus, 15(4). https://doi.org/10.7759/cureus.37777
7) Hidalgo, J. A. S., Fallas, R. S. R., & Pacheco, R. J. A. (2021). Relationship between obesity and bariatric surgery. Revista Médica Sinergia, 6(02), 1-11.

https://doi.org/10.31434/rms.v6i2.640
8) Dakour-Aridi, H. N., El-Rayess, H. M., Abou-Abbass, H., Abu-Gheida, I., Habib, R. H., & Safadi, B. Y. (2017). Safety of concomitant cholecystectomy at the time of laparoscopic sleeve gastrectomy: analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Surgery for Obesity and Related Diseases, 13(6), 934-941. https://doi.org/10.1016/j.soard.2016.12.012
9) Efectividad de la cirugía bariátrica en el tratamiento de la obesidad. (2022). Revista Eugenio Espejo (En LíNea)/Revista Eugenio Espejo, 16(2), 25-34.

https://doi.org/10.37135/ee.04.14.04
10) Misra, S., & Bhasker, A. G. (2023). Gallstones and Bariatric Surgery. En Springer eBooks (pp. 1381-1393). https://doi.org/10.1007/978-3-030-60596-4_111
11) Alsallamin, I., Chakhachiro, D., Bawwab, A., Nassar, M., & Alsallamin, A. (2023). Prevalence of Symptomatic Gallbladder Disease After Bariatric Surgery: A Literature Review. Curēus. https://doi.org/10.7759/cureus.37777
12) Haal, S., Guman, M. S. S., Bruin, S. C., Schouten, R., Van Veen, R. N., Fockens, P., Dijkgraaf, M. G. W., Hutten, B. A., Gerdes, V. E. A., & Voermans, R. P. (2022). Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery. Obesity Surgery, 32(4), 1270-1278. https://doi.org/10.1007/s11695-022-05947-8
13) Arterburn, D., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020). Benefits and Risks of Bariatric Surgery in Adults. JAMA, 324(9), 879.

https://doi.org/10.1001/jama.2020.12567
14) Bjørklund, G., Semenova, Y., Pivina, L., & Costea, D. (2020). Follow-up after bariatric surgery: A review. Nutrition, 78, 110831. https://doi.org/10.1016/j.nut.2020.110831
15) Van Olst, N., Vink, M., De Vet, S. C. P., Hutten, B. A., Gerdes, V. E. A., Tielbeek, J. A. W., Bruin, S. C., Van Weyenberg, S. J., Van Der Peet, D. L., & Acherman, Y. I. Z. (2023). A Prospective Study on the Diagnoses for Abdominal Pain After Bariatric Surgery: The OPERATE Study. Obesity Surgery, 33(10), 3017-3027. https://doi.org/10.1007/s11695-023-06756-3
16) Cunningham, R., Jones, K., Kuhn, J., Dove, J. T., Horsley, R., Daouadi, M., Gabrielsen, J., Petrick, A., & Parker, D. M. (2020). Asymptomatic Cholelithiasis and Bariatric Surgery: a Comprehensive Long-Term Analysis of the Risks of Biliary Disease in Patients Undergoing Primary Roux-en-Y Gastric Bypass. Obesity Surgery, 31(3), 1249-1255. https://doi.org/10.1007/s11695-020-05125-8
17) De Lucena, A. V. S., Cordeiro, G. G., Leão, L. H. A., Kreimer, F., De Siqueira, L. T., Da Conti Oliveira Sousa, G., De Lucena, L. H. S., & Ferraz, Á. A. B. (2022). Cholecystectomy Concomitant with Bariatric Surgery: Safety and Metabolic Effects. Obesity Surgery, 32(4), 1093-1102. https://doi.org/10.1007/s11695-022-05889-1
18) Somasekar, K., Chan, D., Sreekumar, N. S., & Anwer, S. (2018). Choledocholithiasis after Bariatric Surgery—More than a Stone’s Throw to Reach? Journal Of Gastrointestinal Surgery, 22(3), 529-537. https://doi.org/10.1007/s11605-017-3634-4
19) Azhri, A. S., Almuqati, A., Azzeh, F. S., Alamro, N., Azhar, W., Qadhi, A., & Ghafouri, K. (2023). Factors influencing body weight one year after bariatric surgery. Medicine, 102(11), e33111. https://doi.org/10.1097/md.0000000000033111
20) Morais, M., Faria, G., Preto, J., & Costa-Maia, J. (2016). Gallstones and Bariatric Surgery: To Treat or Not to Treat? World Journal Of Surgery, 40(12), 2904-2910. https://doi.org/10.1007/s00268-016-3639-2
21) Dai, Y., Luo, B., & Li, W. (2023). Incidence and risk factors for cholelithiasis after bariatric surgery: a systematic review and meta-analysis. Lipids In Health And Disease, 22(1). https://doi.org/10.1186/s12944-023-01774-7
22) Nogueiro, J., Santos‐Sousa, H., Ribeiro, M. Â., Cruz, F., Pereira, A., Resende, F., Costa-Pinho, A., Preto, J., Sousa‐Pinto, B., Lima-Da-Costa, E., & Carneiro, S. (2023). Incidence of symptomatic gallstones after bariatric surgery: the impact of expectant management. Langenbeck’s Archives Of Surgery, 408(1). https://doi.org/10.1007/s00423-023-02904-6
23) Andrés-Imaz, A., Martí-Gelonch, L., Eizaguirre-Letamendia, E., Asensio-Gallego, J. I., & Enríquez-Navascués, J. M. (2021). Incidencia y factores de riesgo para el desarrollo de colelitiasis tras cirugía bariátrica. Cirugía Española/Cirugia Española, 99(9), 648-654. https://doi.org/10.1016/j.ciresp.2020.10.021
24) Nagem, R. G., Alberti, L. R., & De Campos-Lobato, L. F. (2020). Is It Safe to Recommend Cholecystectomy Whenever Gallstones Develop After Bariatric Surgery? Obesity Surgery, 31(1), 179-184. https://doi.org/10.1007/s11695-020-04862-0
25) Tustumi, F., Filho, J. E. L. P., Stolzemburg, L., Serigiolle, L. C., Costa, T. N., Pajecki, D., Santo, M. A., & Nahas, S. C. (2022). Management of biliary stones in bariatric surgery. Therapeutic Advances In Gastrointestinal Endoscopy, 15, 263177452211050. https://doi.org/10.1177/26317745221105087
26) Frigolet, M. E., Kim, D., Canizales‐Quinteros, S., & Gutiérrez‐Aguilar, R. (2020). Obesidad, tejido adiposo y cirugía bariátrica. Boletín Médico del Hospital Infantil de México/Boletín Médico del Hospital Infantil de México, 77(1). https://doi.org/10.24875/bmhim.19000115
27) Barzin, M., Andalib, A., Khalaj, A., Mahdavi, M., Valizadeh, M., Mousapour, P., & Hosseinpanah, F. (2021). Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study. Obesity Surgery, 32(2), 311-317. https://doi.org/10.1007/s11695-021-05777-0
28) Hidalgo, J. A. S., Fallas, R. S. R., & Pacheco, R. J. A. (2021). Relación de obesidad y cirugía bariatrica. Revista Médica Sinergía/Revista Médica Sinergia, 6(2), e640. https://doi.org/10.31434/rms.v6i2.640
29) McCarty, T. R., & Kumar, N. (2022). Revision Bariatric Procedures and Management of Complications from Bariatric Surgery. Digestive Diseases And Sciences, 67(5), 1688-1701. https://doi.org/10.1007/s10620-022-07397-9
30) Altalhi, R. A., Alsaqqa, R. M., Alasmari, R. M., Aljuaid, A., Althobaiti, L., & Mahfouz, M. (2023). The Incidence of Cholelithiasis After Bariatric Surgery in Saudi Arabia and Its Associated Risk Factors. Curēus. https://doi.org/10.7759/cureus.40549
31) Yıldırım, K., Karabıçak, İ., Gursel, M. F., Karabıçak, C., & Malazgirt, Z. (2023). The outcome of concomitant cholecystectomy with bariatric surgery: a retrospective cohort study. Annals Of Medicine And Surgery, 85(4), 718-721.

https://doi.org/10.1097/ms9.0000000000000339
32) Mulliri, A., Menahem, B., Alvès, A., & Dupont, B. (2022). Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials. Journal Of Gastroenterology, 57(8), 529-539. https://doi.org/10.1007/s00535-022-01886-4
33) FICHA TÉCNICA Ursobilane. (s. f.). En Agencia Española de Medicamentos y Productos Sanitarios. MINISTERIO DE SANIDAD, POLITICA SOCIAL E IGUALDAD. Recuperado 1 de julio de 2024, de

https://cima.aemps.es/cima/pdfs/es/ft/56177/56177_ft.pdf
34) Della Penna, A., Lange, J., Hilbert, J., Archid, R., Königsrainer, A., & Quante, M. (2019). Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones. Obesity Surgery, 29(4), 1216-1221. https://doi.org/10.1007/s11695-018-03651-0
35) Coupaye, M., Calabrese, D., Sami, O., Siauve, N., & Ledoux, S. (2019). Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy. Obesity Surgery, 29(8), 2464-2469. https://doi.org/10.1007/s11695-019-03862-z
36) Uy, M. C., Talingdan-Te, M. C., Espinosa, W. Z., Daez, M. L. O., & Ong, J. P. (2008). Ursodeoxycholic Acid in the Prevention of Gallstone Formation after Bariatric Surgery: A Meta-analysis. Obesity Surgery, 18(12), 1532-1538. https://doi.org/10.1007/s11695-008-9587-7
37) Adams, L. B., Chang, C., Pope, J., Kim, Y., Liu, P., & Yates, A. (2015). Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy. Obesity Surgery, 26(5), 990-994. https://doi.org/10.1007/s11695-015-1858-5
38) Coupaye, M., Calabrese, D., Sami, O., Msika, S., & Ledoux, S. (2017). Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surgery For Obesity And Related Diseases, 13(4), 681-685. https://doi.org/10.1016/j.soard.2016.11.022